EP Patent

EP4729510A1 — Indole compound, preparation method therefor and use thereof

Assigned to Suzhou Merna Therapeutics Co Ltd · Expires 2026-04-22 · 0y expired

What this patent protects

A compound of formula I, or a stereoisomer, a tautomer, a solvate, a hydrate, a prodrug, a stable isotope derivative, and a pharmaceutically acceptable salt thereof is provided:The compound has activity in preventing and/or treating a skin-related disease.

USPTO Abstract

A compound of formula I, or a stereoisomer, a tautomer, a solvate, a hydrate, a prodrug, a stable isotope derivative, and a pharmaceutically acceptable salt thereof is provided:The compound has activity in preventing and/or treating a skin-related disease.

Drugs covered by this patent

Patent Metadata

Patent number
EP4729510A1
Jurisdiction
EP
Classification
—
Expires
2026-04-22
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Merna Therapeutics Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.